Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2/3 1Phase 2 1

Status

Recruiting 4Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other 2Genitourinary 2

Conditions

Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Obesity 2

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Interventional × semaglutide × Clear all
NCT07202247 2026-02-04

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

City of Hope Medical Center

Phase 2 Recruiting
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT05819853 2025-08-28

RESTORE

University of Colorado, Denver

Phase 3 Recruiting
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT06908694 2025-07-29

GAINPCCONTROL

Hamilton Health Sciences Corporation

Phase 4 Recruiting
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT06896981 2025-04-02

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 2/3 Recruiting
30 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡